This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Johnson & Johnson Is Rewarding but Too Expensive

Stocks in this article: JNJ DBD PG VZ

NEW YORK ( TheStreet) -- Johnson & Johnson (JNJ) continues to be a very popular dividend-paying stock among buy-and-hold investors. Yet, over 8.2 million shares of the diversified health care company trade hands daily.

J&J is an expensive stock. At nearly $101, as of Wednesday's close, shares are up 10% for the year to date and nearly 18% for the past 52 weeks. Can that high price be sustained? No, and that's why I see a correction coming.

Let's look at the numbers: J&J's first-quarter financial numbers included 3.5% sales growth and an almost 7% EPS increase over the year-ago quarter. Worldwide consumer sales of $3.6 billion for the quarter represented a decrease of 3.2% versus the same quarter in 2013.

On April 24 the Board of Directors declared a 6.1% increase in the quarterly dividend rate, from 66 cents per share to 70 cents per share. It was the 52nd consecutive year this shareholder-friendly company has raised its dividend.

Only Diebold (DBD) and Procter & Gamble (PG), to my knowledge, have longer records of consecutive annual dividend increases with 60 years and 58 years. Annual dividend raises are important to investors but isn't the best criterion for when to buy a company's stock.

Shareholders of Johnson & Johnson who did buy at more reasonable share price levels have been rewarded generously. Since the February 4 low of $86.09 JNJ shares moved up over 18% in less than three months topping out at $101.98 on April 29. This is  illustrated in the one-year chart below.

JNJ Chart
JNJ
data by YCharts

Notice the declining direction in the red quarterly revenue per share line during the first quarter. This is concerning and needs to be watched carefully. After a big drop in the free cash flow per share in the last quarter of 2013 (orange line) it's significant that it started recovering in the first quarter of 2014.

But the big question investors need to be asking now is whether the share price for Johnson & Johnson's stock will stay at current levels.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,914.55 +109.75 0.62%
S&P 500 2,075.76 +5.11 0.25%
NASDAQ 4,777.7890 +12.4090 0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs